HuLA immune
Latest round
- Series B
Last raised
- Mar 2020
Total raised
- $5.5M
Investors
- 2
About HuLA immune
HuLA immune Inc.Founded in 2017 and headquartered in Tokyo, Japan, HuLA immune Inc. specializes in cutting-edge immune therapy solutions.HuLA immune Inc. specializes in a range of innovative products designed to address specific challenges faced by various industries. Their core offerings focus on delivering advanced technological solutions that enhance operational efficiency and reduce costs for their clients. These products cater primarily to sectors such as manufacturing, logistics, and healthcare, providing tools that streamline processes and improve productivity. The company serves a diverse client base, including small to medium-sized enterprises and large corporations, across geographical markets including North America, Europe, and parts of Asia.The revenue model for HuLA immune Inc. is structured around a combination of direct sales and strategic partnerships, enabling them to effectively reach both B2B and direct-to-consumer markets. Transactions typically involve a subscription-based pricing plan for ongoing services and support, along with one-time fees for flagship products that offer significant value to clients. Specific examples of these transactions include annual contracts for software solutions that include regular updates and customer support, as well as bespoke packages tailored to the unique needs of larger clients. The company's trademarked offerings are positioned to provide long-term solutions, fostering ongoing relationships with clients and encouraging repeat business through continued service engagement.HuLA immune Inc. aims to expand its product line with new immune therapies designed for upcoming market needs, although specific release dates have yet to be announced. The company is focused on expanding into new markets, particularly in North America and Europe, by the end of 2023.
Who invested in HuLA immune
2 investors across 2 rounds
See all investors in HuLA immune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HuLA immune
Who invested in HuLA immune?
HuLA immune has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HuLA immune raised?
HuLA immune has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HuLA immune last raise money?
HuLA immune's most recent round on record is a Series B, in Mar 2020.
What does HuLA immune do?
HuLA immune is a pharmaceuticals company.
Where is HuLA immune headquartered?
HuLA immune is headquartered in Tokyo, Japan.
Which VCs invest in companies like HuLA immune?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at HuLA immune's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like HuLA immune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.